Michael R.

Michael R. is currently the Chief Executive Officer at Corellia AI, a company Michael launched in 2023, leveraging their deep understanding of cancer biology gained during their time at Pfizer and Champions Oncology, Inc. Prior to this, Michael held various roles in business development and research in the oncology field. Michael holds a Ph.D. in Biochemistry from Temple University and an M.B.A. in Finance from NYU Stern School of Business.